Cephalon Inc.'s experimental drug to treat attention deficit hyperactivity disorder may have fallen victim more to the timing of its audition than the quality of its performance, some experts say.
Cephalon Inc.'s experimental drug to treat attention deficit hyperactivity disorder may have fallen victim more to the timing of its audition than the quality of its performance, some experts say.
